Showing results (401-410 of 1,811) with videos related to
Sort By:
Pageof 182
Transplantation and Cellular Therapy|July 2, 2023
Negative Prognostic Impact of High-Dose or Long-Term Corticosteroid Use in Patients with Relapsed or Refractory B-Cell Lymphoma Who Received TisagenlecleucelToshiki Terao, Wataru Kitamura, Nobuharu Fujii, et al.Transplantation and Cellular Therapy|June 13, 2023
Leukapheresis and Tisagenlecleucel Manufacturing Outcomes in Patients Age <3 Years with Relapsed/Refractory Acute Lymphoblastic LeukemiaDavid Fong, Ranjan Tiwari, Christopher Acker, et al.Transplantation and Cellular Therapy|July 14, 2026
Discontinuing Ciprofloxacin Prophylaxis in Allogeneic Stem Cell Transplantation Does Not Result in Inferior OutcomesKrischan Braitsch, Vanessa Möbius, Katrin Koch, et al.Transplantation and Cellular Therapy|July 31, 2026
Haploidentical hematopoietic stem cell transplantation drives time-dependent premature T cell senescence: Recipient microenvironment modulates donor T cell epigenetic aging, telomere homeostasis and SASP remodelingLin Sun, Yichen Zhang, Hong Zhang, et al.Transplantation and Cellular Therapy|August 5, 2026
Impact of Prior Bendamustine Exposure on Chimeric Antigen Receptor T-Cell Therapy Outcomes in Follicular LymphomaDanielle DeCicco, Sanjana Nethagani, Shanawar Waris, et al.Transplantation and Cellular Therapy|June 24, 2026
CAR-T CELLS FATE AFTER INFUSION: CELLULAR KINETICS AND MOLECULAR MONITORINGLuisa Anelli, Cosimo Cumbo, Angela Minervini, et al.Transplantation and Cellular Therapy|June 18, 2026
Clinical trials in graft-versus-host disease: changes in study characteristics, investigated drugs, and endpoints over timePhilipp Melhorn, Nina Dominik, Lina Zoe Rüsing, et al.Transplantation and Cellular Therapy|June 27, 2026
Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)Rawan G Faramand, Amy Zhang, Gregory W Roloff, et al.Transplantation and Cellular Therapy|April 19, 2026
Austrian real-world experience with standard of care brexucabtagene autoleucel in patients with relapsed or refractory mantle-cell lymphomaStefan Koeck, Natalia Rotter, Olga Stiefel, et al.Transplantation and Cellular Therapy|April 29, 2026
Real-World Validation of the Transplant Conditioning Intensity (TCI) Score in Allogeneic Hematopoietic Cell Transplantation: A Spanish Multicenter Study on behalf of GETH-TCAnnalisa Paviglianiti, Estefania Perez Lopez, Alejandro Avendaño, et al.Pageof 182